Screener
Halozyme Therapeutics HALO Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Halozyme Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Halozyme Therapeutics’s 10-Q, filed November 3, 2025. Open the filing →
- Filed
- Nov 3, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001159036-25-000045
FAQ
- What is Halozyme Therapeutics's net margin?
- Halozyme Therapeutics (HALO) reported net margin of 47.9% in Q3 2025.
- How has Halozyme Therapeutics's net margin changed year-over-year?
- Halozyme Therapeutics's net margin increased by 15.7% year-over-year, from 41.4% to 47.9%.
- What is the long-term trend for Halozyme Therapeutics's net margin?
- Over 4 years (2020 to 2024), Halozyme Therapeutics's net margin has grown at a -2.4% compound annual growth rate (CAGR), from 48.2% to 43.7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Halozyme Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude